Brain Quality Control Selectively Eliminates Neurons with Abnormal Variants in Development
Scientists from Harvard Medical School and Boston Children’s Hospital have uncovered a significant quality-control mechanism…
Newswire
Federal Judge Blocks New Medicaid ‘Frailty’ Definition, Delaying Work Requirements
The rollout of Medicaid work requirements may face significant delays following a federal judge’s ruling…
First Whole-Body Single-Cell Atlas of Adult Vertebrate Generated in Danionella cerebrum
Whitehead Institute researchers have created the first comprehensive whole-body single-cell atlas of an adult vertebrate,…
Clinical Supply Chain Resilience in a New Operating Reality
Deepening global geopolitical instability has led some experts to warn that the pharmaceutical industry could…
STAT+ Reveals EPIC Investigation and Unanticipated Developments from Teladoc
STAT has announced its participation in the HLTH conference in Las Vegas on November 18,…
ICH Adopts New M15 Guideline for Model-Informed Drug Development
Adopted by the International Council for Harmonisation (ICH) in February 2026, the new ICH M15…
Genmab Soars to Record Highs After Cancer Drug Succeeds in Key Trial
Genmab’s market capitalization surged by over $7 billion following positive trial results for a recently-acquired…
RFK Jr backs compounding of six unapproved peptides in new policy
In a significant move for the pharmaceutical compounding sector, Robert F. Kennedy Jr. has endorsed…
Gaelic Labs: the EU Critical Medicines Act will have a positive impact on supply
Gaelic Labs anticipates significant advantages stemming from the EU’s Critical Medicines Act, which aims to…
HHS to Allow Compounders to Make 6 Unapproved Peptides
The U.S. Department of Health and Human Services (HHS) has announced that it will not…